{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:11:12Z","timestamp":1790615472464,"version":"4.1.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anaerobe"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.anaerobe.2009.08.004","type":"journal-article","created":{"date-parts":[[2009,8,19]],"date-time":"2009-08-19T08:33:54Z","timestamp":1250670834000},"page":"290-291","source":"Crossref","is-referenced-by-count":104,"title":["Rifaximin Redux: Treatment of recurrent Clostridium difficile infections with Rifaximin immediately post-vancomycin treatment"],"prefix":"10.1016","volume":"15","author":[{"given":"Stuart","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Schriever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toral","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Hecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale N.","family":"Gerding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anaerobe.2009.08.004_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S0924-8579(09)70014-7","article-title":"Recurrent Clostridium difficile infection: causality and therapeutic approaches","author":"Johnson","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.anaerobe.2009.08.004_bib2","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1086\/511870","article-title":"Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin","volume":"44","author":"Johnson","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anaerobe.2009.08.004_bib3","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1128\/AAC.01623-06","article-title":"In vitro activities of 15 antimicrobial agents against 110 toxigenic Clostridium difficile clinical isolates collected from 1983 to 2004","volume":"51","author":"Hecht","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.anaerobe.2009.08.004_bib4","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1128\/AAC.00342-08","article-title":"Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile","volume":"52","author":"O'Connor","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.anaerobe.2009.08.004_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MCG.0b013e31814a4e97","article-title":"Rifaximin in treatment of recurrent Clostridium difficile-associated diarrhea: an uncontrolled pilot Study","volume":"43","author":"Garey","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.anaerobe.2009.08.004_bib6","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1128\/AAC.44.8.2205-2206.2000","article-title":"In vitro activity and fecal concentration of rifaximin after oral administration","volume":"44","author":"Jiang","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.anaerobe.2009.08.004_bib7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7326\/0003-4819-117-4-297","article-title":"Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial","volume":"117","author":"Johnson","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.anaerobe.2009.08.004_bib8","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7326\/0003-4819-142-10-200505170-00005","article-title":"A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea","volume":"142","author":"DuPont","year":"2005","journal-title":"Ann Intern Med"}],"container-title":["Anaerobe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107599640900119X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107599640900119X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T19:21:21Z","timestamp":1545074481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107599640900119X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S107599640900119X"],"URL":"https:\/\/doi.org\/10.1016\/j.anaerobe.2009.08.004","relation":{},"ISSN":["1075-9964"],"issn-type":[{"value":"1075-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}